Gender differences in microRNA expression in levodopa-naive PD patients

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• Parkinson's disease (PD) exhibits gender-specific epidemiological and clinical characteristics.
• MicroRNAs (miRNAs) are implicated in the pathophysiology and progression of neurodegenerative diseases.
• Understanding gender differences in miRNA expression may reveal novel therapeutic targets for PD.

Purpose of the Study:

• To investigate gender-specific differences in the serum expression of selected miRNAs in Parkinson's disease patients.
• To explore potential correlations between miRNA expression levels and clinical parameters in PD.
• To identify potential biological pathways influenced by gender-specific miRNA expression in PD.

Main Methods:

• Serum samples were collected from 104 de novo Parkinson's disease patients (58 males, 46 females).
• Quantitative PCR was employed to measure the expression levels of miR-34a-5p, miR-146a, miR-155, miR-29a, and miR-106a.
• Spearman's correlation test and STRING database analysis were used to assess relationships between miRNA expression, clinical data, and gene co-expression networks.

Main Results:

• miR-34a-5p was significantly upregulated in male PD patients compared to female PD patients (fold change: 1.62, p < 0.0001).
• miR-146a-5p was significantly upregulated in female PD patients compared to male PD patients (fold change: 3.44, p < 0.0001), with higher expression correlating with longer disease duration.
• No significant gender-based differences were observed for miR-29a, miR-106a-5p, and miR-155 expression; no correlations with age, BMI, or UPDRS III scores were found.

Conclusions:

• The study provides evidence for gender-specific differences in serum miRNA expression profiles in Parkinson's disease patients.
• These identified miRNAs (miR-34a-5p and miR-146a-5p) may play distinct roles in the pathogenesis or progression of PD between genders.
• Further longitudinal studies are warranted to determine if these miRNA expression differences impact disease progression and treatment response in PD.